Article Correctness Is Author's Responsibility: AI preclinical research program targeting brain cancers starts at Insilico Medicine

(InSilico Medicine) New AI-powered discovery generative biology and generative chemistry effort targeting brain tumors with the focus on GBM launches at Insilico Medicine.